Leiner recapitalization
This article was originally published in The Tan Sheet
Executive Summary
Golden Gate Capital, along with Leiner majority stakeholder North Castle, will take a $265 mil. investment in the private label firm as part of a $650 recapitalization deal. Lead underwriter UBS will provide the remaining $385 through the purchase of junk bonds and senior notes. Leiner originally was put up for sale in February (1"The Tan Sheet" Feb. 23, 2004, p. 3)...
You may also be interested in...
Leiner Ownership Expected To Change Hands In Recapitalization Deal
North Castle Partners is reportedly in the second round of talks to sell its stake in Leiner Health Products to another private equity firm
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.